反応式
[CH3:1][C:2]1[N:3]=[C:4]([C:21]([O:23]CC)=[O:22])[S:5][C:6]=1[CH2:7][C:8]1[CH:13]=[CH:12][CH:11]=[C:10]([N:14]2[CH2:19][CH2:18][N:17]([CH3:20])[CH2:16][CH2:15]2)[CH:9]=1.O[Li].O>C1COCC1.O>[CH3:1][C:2]1[N:3]=[C:4]([C:21]([OH:23])=[O:22])[S:5][C:6]=1[CH2:7][C:8]1[CH:13]=[CH:12][CH:11]=[C:10]([N:14]2[CH2:15][CH2:16][N:17]([CH3:20])[CH2:18][CH2:19]2)[CH:9]=1参加物
5
実験手順
A solution of ethyl 4-methyl-5-(3-(4-methylpiperazin-1-yl)benzyl)thiazole-2-carboxylate (270 mg, 0.72 mmol) was treated with LiOH.H2O (61 mg, 1.45 mmol) in THF (4 mL) and H2O (1 mL), and stirred at RT for 2 h. The solvents were removed under reduced pressure and the residue was purified by Combiflash (20% MeCN/H2O) to afford 4-methyl-5-(3-(4-methylpiperazin-1-yl)benzyl)thiazole-2-carboxylic acid as a yellow solid (70 mg, 29%). MS (ES+) C17H21N3O2S requires: 331, found: 332[M+H]+.
後処理
- customThe solvents were removed under reduced pressure
- customthe residue was purified by Combiflash (20% MeCN/H2O)
出典と根拠
- ORDレコード
- ord-71ff6943f6964a87b6869327e2794926
- 出典データセット
- uspto-grants-2015_08
- 特許番号
- US09115120B2
関連ノート
読み込み中…